{"id":6182,"date":"2021-02-10T11:53:53","date_gmt":"2021-02-10T10:53:53","guid":{"rendered":"https:\/\/www.future-live.com\/?page_id=6182"},"modified":"2021-02-10T11:54:35","modified_gmt":"2021-02-10T10:54:35","slug":"candida-albicans-what-is-it","status":"publish","type":"page","link":"https:\/\/www.future-live.com\/en\/candida-albicans-what-is-it\/","title":{"rendered":"Vaginal Candida: what is it?"},"content":{"rendered":"

[vc_row][vc_column][tm_spacer size=”lg:32″][vc_single_image image=”951″ img_size=”800X400″ alignment=”center”][tm_spacer size=”lg:32″][vc_column_text]<\/p>\n

CANDIDA ALBICANS: WHAT IS IT?\u00a0<\/strong><\/h2>\n

[\/vc_column_text][tm_spacer size=”lg:32″][vc_column_text css=”.vc_custom_1612954104446{padding-right: 15px !important;padding-left: 15px !important;}”]Candida albicans is a yeast that belongs to the class of Saccharomyces. It is normally present in the oral cavity, intestine and vagina as a saprophyte without any annoying clinical manifestation.<\/p>\n

It can become pathogenic in particular conditions such as pregnancy, antibiotic abuse and stress. In these cases, particularly at the vaginal level, Candida albicans transforms into the pathogenic form (hyphal form) and adheres to the vaginal epithelium with the production of enzymes responsible for the inflammatory process.[\/vc_column_text][tm_spacer size=”lg:32″][\/vc_column][\/vc_row][vc_row][vc_column][tm_spacer size=”lg:32″][vc_single_image image=”4798″ img_size=”800X400″ alignment=”center”][tm_spacer size=”lg:32″][vc_column_text]<\/p>\n

VAGINITIS FROM CANDIDA ALBICANS: RELAPSES<\/strong><\/p>\n

Candida albicans vaginitis is one of the most common vaginal infections, representing around 50% of all cases of infectious vulvovaginitis.\u00a0 It manifests as a white, curd-like vaginal discharge, odourless and with severe itching and significant inflammation of the external genitalia.<\/p>\n

Candida albicans vaginitis is very common in the female population, about 75% of women suffer from it at least once in their lifetime and relapses occurring after the first episode are very common. Particularly significant is the fact that 4-8% of women suffer from recurring Candida albicans vaginitis at least 4 times a year.<\/p>\n

<\/h2>\n

 <\/p>\n

VAGINITIS FROM CANDIDA ALBICANS: THE THERAPY<\/strong><\/p>\n

Treatment involves the use of specific antifungals for topical use (ova or cream) for 7-14 days or the use of systemic antifungals for 1-3 days.<\/p>\n

The therapy for recurrent Candida albicans vaginitis is more complex with the presence of at least 4 episodes per year. In these cases, basic treatment is recommended, which must be combined with oral antifungal treatment for at least 6 months.[\/vc_column_text][tm_spacer size=”lg:32″][vc_single_image image=”4958″ img_size=”800X400″ alignment=”center”][tm_spacer size=”lg:32″][vc_column_text]SACCHAROMYCES CEREVISIAE CNCM I-3856 AND RECURRING VAGINITIS<\/strong><\/p>\n

Saccharomyces Cerevisie is a healthy yeast normally used in the food industry for its ability to ferment sugars. Saccharomyces Cerevisiae<\/strong> CNCM I-3856<\/strong> is a specific strain specially selected and studied, both at a microbiological and clinical level, to restore the balance of thee vaginal flora.<\/p>\n

In particular, this yeast strain has been the subject of a clinical study that has demonstrated a probiotic activity that antagonizes Candida albicans and accelerates the restoration of normal vaginal flora, improving its functionality and physiological state and consequently limiting the possibility of new external aggressions by other potentially harmful yeasts such as Candida albicans.<\/p>\n

Therefore, these studies demonstrate that taking Saccharomyces Cerevisiae<\/strong> CNCM I-3856<\/strong> makes drug treatment with antifungals more effective and prevents recurrence of relapses while simultaeously limiting the inflammation of the vagina.<\/p>\n

 <\/p>\n

SACCHAROMYCES CEREVISIAE CNCM I-3856 AND PREGNANCY<\/strong><\/p>\n

Candida vaginitis is particularly common in pregnancy, in fact it effects about 1 in 3 women. Saccharomyces Cerevisiae<\/strong> CNCM I-3856<\/strong> has no side effects and can be used safely during pregnancy.[\/vc_column_text][tm_spacer size=”lg:32″][vc_column_text css=”.vc_custom_1612954295630{padding-right: 15px !important;padding-left: 15px !important;}”]<\/p>\n

For further information, please use the contact form which is available via the menu at the top of the page<\/em><\/p>\n

[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"[vc_row][vc_column][tm_spacer size=”lg:32″][vc_single_image image=”951″ img_size=”800X400″ alignment=”center”][tm_spacer size=”lg:32″][vc_column_text] CANDIDA ALBICANS: WHAT IS IT?\u00a0 [\/vc_column_text][tm_spacer size=”lg:32″][vc_column_text css=”.vc_custom_1612954104446{padding-right: 15px !important;padding-left: 15px !important;}”]Candida albicans is a yeast that belongs to the class of Saccharomyces. It is normally present in the oral cavity, intestine and vagina as a saprophyte without any annoying clinical manifestation. It can become pathogenic in particular conditions such as pregnancy, antibiotic abuse and stress. In these cases, particularly at the vaginal level, Candida albicans transforms into the pathogenic form (hyphal form) and adheres to the vaginal epithelium with the production of enzymes responsible for the inflammatory process.[\/vc_column_text][tm_spacer size=”lg:32″][\/vc_column][\/vc_row][vc_row][vc_column][tm_spacer size=”lg:32″][vc_single_image image=”4798″ img_size=”800X400″ alignment=”center”][tm_spacer size=”lg:32″][vc_column_text] VAGINITIS FROM CANDIDA ALBICANS: RELAPSES Candida albicans vaginitis is one of the most common vaginal infections, representing around 50% of all cases of infectious vulvovaginitis.\u00a0 It manifests as a white, curd-like vaginal discharge, odourless and with severe itching and significant inflammation of the external genitalia. Candida albicans vaginitis is very common in the female population, about 75% of women suffer from it at least once in their lifetime and relapses occurring after the first episode are very common. Particularly significant is the fact that 4-8% of women suffer from recurring Candida albicans vaginitis at least 4 times a year.   VAGINITIS FROM CANDIDA ALBICANS: THE THERAPY Treatment involves the use of specific antifungals for topical use (ova or cream) for 7-14 days or the use of systemic antifungals for 1-3 days. The therapy for recurrent Candida albicans vaginitis is more complex with the presence of at least 4 episodes per year. In these cases, basic treatment is recommended, which must be combined with oral antifungal treatment for at least 6 months.[\/vc_column_text][tm_spacer size=”lg:32″][vc_single_image image=”4958″ img_size=”800X400″ alignment=”center”][tm_spacer size=”lg:32″][vc_column_text]SACCHAROMYCES CEREVISIAE CNCM I-3856 AND RECURRING VAGINITIS Saccharomyces Cerevisie is a healthy yeast normally used in the food industry for its ability to ferment sugars. Saccharomyces Cerevisiae CNCM I-3856 is a specific strain specially selected and studied, both at a microbiological and clinical level, to restore the balance of thee vaginal flora. In particular, this yeast strain has been the subject of a clinical study that has demonstrated a probiotic activity that antagonizes Candida albicans and accelerates the restoration of normal vaginal flora, improving its functionality and physiological state and consequently limiting the possibility of new external aggressions by other potentially harmful yeasts such as Candida albicans. Therefore, these studies demonstrate that taking Saccharomyces Cerevisiae CNCM I-3856 makes drug treatment with antifungals more effective and prevents recurrence of relapses while simultaeously limiting the inflammation of the vagina.   SACCHAROMYCES CEREVISIAE CNCM I-3856 AND PREGNANCY Candida vaginitis is particularly common in pregnancy, in fact it effects about 1 in 3 women. Saccharomyces Cerevisiae CNCM I-3856 has no side effects and can be used safely during pregnancy.[\/vc_column_text][tm_spacer size=”lg:32″][vc_column_text css=”.vc_custom_1612954295630{padding-right: 15px !important;padding-left: 15px !important;}”] For further information, please use the contact form which is available via the menu at the top of the page [\/vc_column_text][\/vc_column][\/vc_row]","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"yoast_head":"\nVaginal Candida: what is it? - Future Live Srl<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.future-live.com\/en\/candida-albicans-what-is-it\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vaginal Candida: what is it? - Future Live Srl\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column][tm_spacer size=”lg:32″][vc_single_image image=”951″ img_size=”800X400″ alignment=”center”][tm_spacer size=”lg:32″][vc_column_text] CANDIDA ALBICANS: WHAT IS IT?\u00a0 [\/vc_column_text][tm_spacer size=”lg:32″][vc_column_text css=”.vc_custom_1612954104446{padding-right: 15px !important;padding-left: 15px !important;}”]Candida albicans is a yeast that belongs to the class of Saccharomyces. It is normally present in the oral cavity, intestine and vagina as a saprophyte without any annoying clinical manifestation. It can become pathogenic in particular conditions such as pregnancy, antibiotic abuse and stress. In these cases, particularly at the vaginal level, Candida albicans transforms into the pathogenic form (hyphal form) and adheres to the vaginal epithelium with the production of enzymes responsible for the inflammatory process.[\/vc_column_text][tm_spacer size=”lg:32″][\/vc_column][\/vc_row][vc_row][vc_column][tm_spacer size=”lg:32″][vc_single_image image=”4798″ img_size=”800X400″ alignment=”center”][tm_spacer size=”lg:32″][vc_column_text] VAGINITIS FROM CANDIDA ALBICANS: RELAPSES Candida albicans vaginitis is one of the most common vaginal infections, representing around 50% of all cases of infectious vulvovaginitis.\u00a0 It manifests as a white, curd-like vaginal discharge, odourless and with severe itching and significant inflammation of the external genitalia. Candida albicans vaginitis is very common in the female population, about 75% of women suffer from it at least once in their lifetime and relapses occurring after the first episode are very common. Particularly significant is the fact that 4-8% of women suffer from recurring Candida albicans vaginitis at least 4 times a year.   VAGINITIS FROM CANDIDA ALBICANS: THE THERAPY Treatment involves the use of specific antifungals for topical use (ova or cream) for 7-14 days or the use of systemic antifungals for 1-3 days. The therapy for recurrent Candida albicans vaginitis is more complex with the presence of at least 4 episodes per year. In these cases, basic treatment is recommended, which must be combined with oral antifungal treatment for at least 6 months.[\/vc_column_text][tm_spacer size=”lg:32″][vc_single_image image=”4958″ img_size=”800X400″ alignment=”center”][tm_spacer size=”lg:32″][vc_column_text]SACCHAROMYCES CEREVISIAE CNCM I-3856 AND RECURRING VAGINITIS Saccharomyces Cerevisie is a healthy yeast normally used in the food industry for its ability to ferment sugars. Saccharomyces Cerevisiae CNCM I-3856 is a specific strain specially selected and studied, both at a microbiological and clinical level, to restore the balance of thee vaginal flora. In particular, this yeast strain has been the subject of a clinical study that has demonstrated a probiotic activity that antagonizes Candida albicans and accelerates the restoration of normal vaginal flora, improving its functionality and physiological state and consequently limiting the possibility of new external aggressions by other potentially harmful yeasts such as Candida albicans. Therefore, these studies demonstrate that taking Saccharomyces Cerevisiae CNCM I-3856 makes drug treatment with antifungals more effective and prevents recurrence of relapses while simultaeously limiting the inflammation of the vagina.   SACCHAROMYCES CEREVISIAE CNCM I-3856 AND PREGNANCY Candida vaginitis is particularly common in pregnancy, in fact it effects about 1 in 3 women. Saccharomyces Cerevisiae CNCM I-3856 has no side effects and can be used safely during pregnancy.[\/vc_column_text][tm_spacer size=”lg:32″][vc_column_text css=”.vc_custom_1612954295630{padding-right: 15px !important;padding-left: 15px !important;}”] For further information, please use the contact form which is available via the menu at the top of the page [\/vc_column_text][\/vc_column][\/vc_row]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.future-live.com\/en\/candida-albicans-what-is-it\/\" \/>\n<meta property=\"og:site_name\" content=\"Future Live Srl\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/FutureLivesrl\/\" \/>\n<meta property=\"article:modified_time\" content=\"2021-02-10T10:54:35+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.future-live.com\/en\/candida-albicans-what-is-it\/\",\"url\":\"https:\/\/www.future-live.com\/en\/candida-albicans-what-is-it\/\",\"name\":\"Vaginal Candida: what is it? - Future Live Srl\",\"isPartOf\":{\"@id\":\"https:\/\/www.future-live.com\/#website\"},\"datePublished\":\"2021-02-10T10:53:53+00:00\",\"dateModified\":\"2021-02-10T10:54:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.future-live.com\/en\/candida-albicans-what-is-it\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.future-live.com\/en\/candida-albicans-what-is-it\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.future-live.com\/en\/candida-albicans-what-is-it\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.future-live.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vaginal Candida: what is it?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.future-live.com\/#website\",\"url\":\"https:\/\/www.future-live.com\/\",\"name\":\"Future Live Srl\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.future-live.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.future-live.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.future-live.com\/#organization\",\"name\":\"Future Live\",\"url\":\"https:\/\/www.future-live.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.future-live.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.future-live.com\/wp-content\/uploads\/2018\/05\/logo-con-sfondo-bianco.png\",\"contentUrl\":\"https:\/\/www.future-live.com\/wp-content\/uploads\/2018\/05\/logo-con-sfondo-bianco.png\",\"width\":1428,\"height\":1315,\"caption\":\"Future Live\"},\"image\":{\"@id\":\"https:\/\/www.future-live.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/FutureLivesrl\/\",\"https:\/\/www.linkedin.com\/company\/future-live-srl\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vaginal Candida: what is it? - Future Live Srl","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.future-live.com\/en\/candida-albicans-what-is-it\/","og_locale":"en_US","og_type":"article","og_title":"Vaginal Candida: what is it? - Future Live Srl","og_description":"[vc_row][vc_column][tm_spacer size=”lg:32″][vc_single_image image=”951″ img_size=”800X400″ alignment=”center”][tm_spacer size=”lg:32″][vc_column_text] CANDIDA ALBICANS: WHAT IS IT?\u00a0 [\/vc_column_text][tm_spacer size=”lg:32″][vc_column_text css=”.vc_custom_1612954104446{padding-right: 15px !important;padding-left: 15px !important;}”]Candida albicans is a yeast that belongs to the class of Saccharomyces. It is normally present in the oral cavity, intestine and vagina as a saprophyte without any annoying clinical manifestation. It can become pathogenic in particular conditions such as pregnancy, antibiotic abuse and stress. In these cases, particularly at the vaginal level, Candida albicans transforms into the pathogenic form (hyphal form) and adheres to the vaginal epithelium with the production of enzymes responsible for the inflammatory process.[\/vc_column_text][tm_spacer size=”lg:32″][\/vc_column][\/vc_row][vc_row][vc_column][tm_spacer size=”lg:32″][vc_single_image image=”4798″ img_size=”800X400″ alignment=”center”][tm_spacer size=”lg:32″][vc_column_text] VAGINITIS FROM CANDIDA ALBICANS: RELAPSES Candida albicans vaginitis is one of the most common vaginal infections, representing around 50% of all cases of infectious vulvovaginitis.\u00a0 It manifests as a white, curd-like vaginal discharge, odourless and with severe itching and significant inflammation of the external genitalia. Candida albicans vaginitis is very common in the female population, about 75% of women suffer from it at least once in their lifetime and relapses occurring after the first episode are very common. Particularly significant is the fact that 4-8% of women suffer from recurring Candida albicans vaginitis at least 4 times a year.   VAGINITIS FROM CANDIDA ALBICANS: THE THERAPY Treatment involves the use of specific antifungals for topical use (ova or cream) for 7-14 days or the use of systemic antifungals for 1-3 days. The therapy for recurrent Candida albicans vaginitis is more complex with the presence of at least 4 episodes per year. In these cases, basic treatment is recommended, which must be combined with oral antifungal treatment for at least 6 months.[\/vc_column_text][tm_spacer size=”lg:32″][vc_single_image image=”4958″ img_size=”800X400″ alignment=”center”][tm_spacer size=”lg:32″][vc_column_text]SACCHAROMYCES CEREVISIAE CNCM I-3856 AND RECURRING VAGINITIS Saccharomyces Cerevisie is a healthy yeast normally used in the food industry for its ability to ferment sugars. Saccharomyces Cerevisiae CNCM I-3856 is a specific strain specially selected and studied, both at a microbiological and clinical level, to restore the balance of thee vaginal flora. In particular, this yeast strain has been the subject of a clinical study that has demonstrated a probiotic activity that antagonizes Candida albicans and accelerates the restoration of normal vaginal flora, improving its functionality and physiological state and consequently limiting the possibility of new external aggressions by other potentially harmful yeasts such as Candida albicans. Therefore, these studies demonstrate that taking Saccharomyces Cerevisiae CNCM I-3856 makes drug treatment with antifungals more effective and prevents recurrence of relapses while simultaeously limiting the inflammation of the vagina.   SACCHAROMYCES CEREVISIAE CNCM I-3856 AND PREGNANCY Candida vaginitis is particularly common in pregnancy, in fact it effects about 1 in 3 women. Saccharomyces Cerevisiae CNCM I-3856 has no side effects and can be used safely during pregnancy.[\/vc_column_text][tm_spacer size=”lg:32″][vc_column_text css=”.vc_custom_1612954295630{padding-right: 15px !important;padding-left: 15px !important;}”] For further information, please use the contact form which is available via the menu at the top of the page [\/vc_column_text][\/vc_column][\/vc_row]","og_url":"https:\/\/www.future-live.com\/en\/candida-albicans-what-is-it\/","og_site_name":"Future Live Srl","article_publisher":"https:\/\/www.facebook.com\/FutureLivesrl\/","article_modified_time":"2021-02-10T10:54:35+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.future-live.com\/en\/candida-albicans-what-is-it\/","url":"https:\/\/www.future-live.com\/en\/candida-albicans-what-is-it\/","name":"Vaginal Candida: what is it? - Future Live Srl","isPartOf":{"@id":"https:\/\/www.future-live.com\/#website"},"datePublished":"2021-02-10T10:53:53+00:00","dateModified":"2021-02-10T10:54:35+00:00","breadcrumb":{"@id":"https:\/\/www.future-live.com\/en\/candida-albicans-what-is-it\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.future-live.com\/en\/candida-albicans-what-is-it\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.future-live.com\/en\/candida-albicans-what-is-it\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.future-live.com\/en\/"},{"@type":"ListItem","position":2,"name":"Vaginal Candida: what is it?"}]},{"@type":"WebSite","@id":"https:\/\/www.future-live.com\/#website","url":"https:\/\/www.future-live.com\/","name":"Future Live Srl","description":"","publisher":{"@id":"https:\/\/www.future-live.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.future-live.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.future-live.com\/#organization","name":"Future Live","url":"https:\/\/www.future-live.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.future-live.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.future-live.com\/wp-content\/uploads\/2018\/05\/logo-con-sfondo-bianco.png","contentUrl":"https:\/\/www.future-live.com\/wp-content\/uploads\/2018\/05\/logo-con-sfondo-bianco.png","width":1428,"height":1315,"caption":"Future Live"},"image":{"@id":"https:\/\/www.future-live.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/FutureLivesrl\/","https:\/\/www.linkedin.com\/company\/future-live-srl\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/pages\/6182"}],"collection":[{"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/comments?post=6182"}],"version-history":[{"count":0,"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/pages\/6182\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.future-live.com\/en\/wp-json\/wp\/v2\/media?parent=6182"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}